跳至主要内容
临床试验/CTRI/2021/01/030762
CTRI/2021/01/030762已完成未知

A single centre, prospective, observational study to evaluate the efficacy and safety of Colistin with double carbapenem regimen versus other antimicrobial combinations with colistin for treatment of carbapenem resistant enterobacteriaceae infections.

Roopali Somani0 个研究点目标入组 46 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients aged 18 years and above of any gender
  • 2. Inpatients with positive culture for Carbapenem Resistant Enterobactericeae
  • 3. Subjects willing to comply with study related procedures

排除标准

  • 1. Patients with history of Epilepsy
  • 2. Patients with Creatinine Clearance <30 ml/min
  • 3. Patients with any comorbidities that is known to affect the study outcome
  • 4. Pregnant and lactating women.

研究者

发起方
Roopali Somani

相似试验

Efficacy of Double Carbapenem regimen against... | 临床试验